Windsor Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,389
| Closed | -$554K | – | 131 |
|
|
2026
Q1 | $554K | Sell |
6,389
-297
| -4% | -$28.5K | 0.16% | 79 |
|
|
2025
Q4 | $642K | Sell |
6,686
-24
| -0.4% | -$2.33K | 0.18% | 74 |
|
|
2025
Q3 | $639K | Hold |
6,710
| – | – | 0.18% | 74 |
|
|
2025
Q2 | $585K | Sell |
6,710
-201
| -3% | -$17K | 0.17% | 81 |
|
|
2025
Q1 | $621K | Buy |
6,911
+46
| +0.7% | +$4.12K | 0.19% | 73 |
|
|
2024
Q4 | $548K | Sell |
6,865
-50
| -0.7% | -$4.33K | 0.16% | 79 |
|
|
2024
Q3 | $623K | Sell |
6,915
-313
| -4% | -$26.3K | 0.18% | 74 |
|
|
2024
Q2 | $569K | Sell |
7,228
-15
| -0.2% | -$1.23K | 0.18% | 74 |
|
|
2024
Q1 | $631K | Buy |
7,243
+79
| +1% | +$6.74K | 0.2% | 71 |
|
|
2023
Q4 | $590K | Buy |
7,164
+52
| +0.7% | +$3.96K | 0.19% | 74 |
|
|
2023
Q3 | $557K | Buy |
7,112
+516
| +8% | +$43.2K | 0.19% | 72 |
|
|
2023
Q2 | $581K | Buy |
6,596
+61
| +0.9% | +$5.25K | 0.19% | 70 |
|
|
2023
Q1 | $527K | Buy |
6,535
+12
| +0.2% | +$978 | 0.18% | 74 |
|
|
2022
Q4 | $507K | Sell |
6,523
-438
| -6% | -$35.5K | 0.18% | 73 |
|
|
2022
Q3 | $562K | Sell |
6,961
-132
| -2% | -$11.9K | 0.21% | 68 |
|
|
2022
Q2 | $636K | Sell |
7,093
-78
| -1% | -$7.9K | 0.23% | 69 |
|
|
2022
Q1 | $795K | Buy |
7,171
+327
| +5% | +$34.5K | 0.25% | 65 |
|
|
2021
Q4 | $708K | Sell |
6,844
-18
| -0.3% | -$2.08K | 0.21% | 70 |
|
|
2021
Q3 | $860K | Sell |
6,862
-37
| -0.5% | -$4.79K | 0.28% | 57 |
|
|
2021
Q2 | $856K | Sell |
6,899
-98
| -1% | -$12.3K | 0.28% | 58 |
|
|
2021
Q1 | $826K | Buy |
6,997
+8
| +0.1% | +$938 | 0.29% | 58 |
|
|
2020
Q4 | $818K | Sell |
6,989
-35
| -0.5% | -$3.85K | 0.31% | 58 |
|
|
2020
Q3 | $730K | Sell |
7,024
-249
| -3% | -$25K | 0.31% | 61 |
|
|
2020
Q2 | $666K | Sell |
7,273
-56
| -0.8% | -$5.37K | 0.29% | 66 |
|
|
2020
Q1 | $660K | Buy |
7,329
+227
| +3% | +$24.1K | 0.33% | 58 |
|
|
2019
Q4 | $805K | Sell |
7,102
-92
| -1% | -$10.1K | 0.34% | 59 |
|
|
2019
Q3 | $781K | Buy |
7,194
+10
| +0.1% | +$1.04K | 0.35% | 61 |
|
|
2019
Q2 | $699K | Sell |
7,184
-126
| -2% | -$11.5K | 0.32% | 69 |
|
|
2019
Q1 | $665K | Sell |
7,310
-472
| -6% | -$42.2K | 0.31% | 72 |
|
|
2018
Q4 | $707K | Buy |
+7,782
| New | +$727K | 0.37% | 64 |
|
|
2015
Q4 | – | Sell |
-444
| Closed | -$29K | – | 283 |
|
|
2015
Q3 | $29K | Buy |
+444
| New | +$32.7K | 0.02% | 219 |
|
Other funds holding MDT
Windsor Capital Management's MDT Position: Q2 2026 in Review
Windsor Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 6,389 shares — an estimated $554K sold.
Windsor Capital Management first reported a position in MDT in Q3 2015 and held it in 31 quarters. The position peaked at $860K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Windsor Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Windsor Capital Management sold 6,389 Medtronic shares in Q2 2026, an estimated $554K.
- Windsor Capital Management first reported a position in Medtronic in Q3 2015 and held it in 31 quarters.
- Windsor Capital Management's Medtronic position peaked at $860K in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.